SCL Science

SCL Science ROA

The Return on Assets (ROA) of SCL Science (246960.KQ) as of Oct 18, 2026 is -4.92 %. In the previous year, Return on Assets (ROA) was -15.51 % — a change of -68.25% (higher).

ROA

-4.92 %

YoY

-68.25%

Last updated:

In 2025, SCL Science's return on assets (ROA) was -4.92 %, a -68.25% increase from the -15.51 % ROA in the previous year.

The SCL Science ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-23.03 KRW
Jan 1, 2019
-23.15 KRW
Jan 1, 2020
-17.56 KRW
Jan 1, 2021
-15.77 KRW
Jan 1, 2022
-19.38 KRW
Jan 1, 2023
-16.67 KRW
Jan 1, 2024
-15.51 KRW
Jan 1, 2025
-4.92 KRW
The SCL Science ROA history
YEARROAYoY
-4.92 %-68.25%
-15.51 %-6.97%
-16.67 %-14.00%
-19.38 %+22.86%
-15.77 %-10.19%
-17.56 %-24.13%
-23.15 %+0.50%
-23.03 %-67.85%
-71.65 %+547.75%
-11.06 %-81.40%
-59.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SCL Science Stock analysis

What does SCL Science do? SCL Science Inc, listed on the Korean stock exchange with ticker 246960.KQ and ISIN KR7246960009, is a healthcare company headquartered in Seoul, South Korea. The company went public on February 1, 2019, as indicated by its IPO date. SCL Science Inc operates within the healthcare sector, focusing on the development and commercialization of medical products. According to the provided information, the company manufactures and sells hemostatic medical agents, which are used to control bleeding in medical procedures. The company's products include medical hemostats and sealants that utilize biomimetic technology, a technology inspired by natural biological processes. The company's website is innotherapy.com, which may provide further details about its products and services. SCL Science Inc is based in Seoul, South Korea, and its primary business activities are centered around the healthcare industry, specifically in the field of hemostatic solutions. The company's focus on biomimetic technology suggests an innovative approach to developing medical products that mimic natural biological mechanisms. The company's operations are likely aimed at providing medical professionals with effective tools for managing bleeding during surgical and other medical procedures. The company's market presence is within South Korea, though it may have international reach through its website and product distribution channels. The information provided does not include details on the company's revenue, market share, or specific competitors, nor does it mention any acquisitions or key personnel beyond the general description of its business activities. SCL Science is one of the most popular companies on Eulerpool.

ROA Details

Understanding SCL Science's Return on Assets (ROA)

SCL Science's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing SCL Science's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider SCL Science's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in SCL Science’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about SCL Science stock

Return on Assets (ROA) of SCL Science is -4.92 % in 2025.

Return on Assets (ROA) of SCL Science changed from -15.51 % to -4.92 %, representing a -68.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) SCL Science since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s SCL Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — SCL Science

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — SCL Science